- Pfizer (New York, NY)
- …(GDL)and members of the development team to establish, lead, coordinate, and execute the early oncology clinical development plan(s). You will lead the ... disciples to ensure the full scope and remit of Oncology Early Stage Development (OESD)...understanding of Oncology Drug Development especially in Early Development Strong knowledge of clinical procedures,… more
- Pfizer (New York, NY)
- …(GDL)and members of the development team to establish, lead, coordinate, and execute the early oncology clinical development plan(s). You will lead the ... disciples to ensure the full scope and remit of Oncology Early Stage Development (OESD)...understanding of Oncology Drug Development especially in Early Development + Strong knowledge of clinical … more
- Sumitomo Pharma (Albany, NY)
- …therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery, ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim… more
- BMO Financial Group (New York, NY)
- …prices + Ability to analyze clinical trial design and data across early and late- stage oncology trials (including dose escalation, dose-expansion, PFS/OS ... assess viability, competitive positioning, and likelihood of success of pre- clinical and clinical - stage oncology...modeling and valuation skills, with a focus on forecasting early - and mid- stage oncology companies… more
- Sumitomo Pharma (Albany, NY)
- …marketed products in the US, Canada, and Europe, and a diverse pipeline of early - to late- stage assets, we aim to accelerate discovery, research, and development ... therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery,… more
- Sumitomo Pharma (Albany, NY)
- …therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery, ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim… more
- Sumitomo Pharma (Albany, NY)
- …therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery, ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim… more
- Sumitomo Pharma (Albany, NY)
- … landscape + Experience in conducting global clinical trials in both early - and late- stage clinical development, especially protocol development and ... Pharma Switzerland GmbH) focused on addressing patient needs in oncology , urology, women's health, rare diseases, psychiatry & neurology,...concept to clinical study protocol for both early - and late- stage programs + Leads or… more
- Sumitomo Pharma (Albany, NY)
- …therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery, ... experienced individual for the position of **Associate** **Medical Director, Clinical Development - Oncology ** . The associate...With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim… more
- Sumitomo Pharma (Albany, NY)
- …therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery, ... a primary focus on advancing translational research to support oncology programs in clinical trial stages. This...With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim… more
